GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD. The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD
GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD
Year-End Challenge to Fund the Treatment for FSHD!
Year-End Challenge to Fund the Treatment for FSHD! A group of long-time supporters have come forward to challenge the Society’s members and friends to make gifts to Fund the Treatment… Read More »